Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.

Cell Discov
Date: Sep. 10, 2020
Download Curated Data For This Publication
222219
Switch View:
  • Interactions 2